Conference call with Q&A today at 09:00 CET / 08:00 GMT, details provided below IRVINE, CA, and HERSTAL, BELGIUM - February 26, 2020 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced its financial results for the year ended December 31, 2019 and provided a business update and outlook for 2020. Michael K. McGarrity, CEO of MDxHealth, commented: `2019 has been a transformational year for MDxHealth, focused on assessing our business and operating execution with the goal of demonstrating evidence of the turnaround required to deliver results that are sustainable and will build value for all of our stakeholders. `We are confident...
|
